Quest Diagnostics Q3 profit beats estimates; revenue up 8.5% YoY, driven by new customers and partnerships.

Quest Diagnostics Inc. reported Q3 earnings of $2.30 per share, surpassing expectations, with sales reaching $2.49 billion—both higher than analyst estimates. Revenue grew 8.5% year-over-year, driven by new customer acquisitions and expanded partnerships. The company now forecasts 2024 revenue between $9.80 billion and $9.85 billion and adjusted EPS of $8.85 to $8.95. Recent acquisitions, including LifeLabs, contributed to this optimistic outlook.

October 22, 2024
8 Articles

Further Reading